Juliette Audet
Equibles does not estimate personal net worth.
About Juliette Audet
NewAmsterdam Pharma Co N.V. reported in an 8-K filed April 1, 2024 that Juliette Audet resigned as Board of Directors, effective April 1, 2024. NewAmsterdam Pharma Co N.V. reported in an 8-K filed April 1, 2024 that Juliette Audet was appointed Chief Business Officer, effective April 1, 2024.
“In connection with Ms. Audet’s appointment as CBO, the Company’s board of directors (the “Board”) and Ms. Audet determined, as of March 28, 2024, that she will resign, effective April 1, 2024, from the Board.”
“On April 1, 2024, NewAmsterdam Pharma Company N.V. (the “Company”) announced the appointment of Juliette Audet as Chief Business Officer (“CBO”) of the Company.”
Affiliation history
-
NewAmsterdam Pharma Co N.V. (NAMS)
Proxy statement
Start not stated–2025-05-08
Last confirmed by a filing; no departure on record